Oncocyte Corporation Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Oncocyte Corporation's estimated annual revenue is currently $10.5M per year.(i)
  • Oncocyte Corporation's estimated revenue per employee is $155,000

Employee Data

  • Oncocyte Corporation has 68 Employees.(i)
  • Oncocyte Corporation grew their employee count by -50% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M70%N/AN/A
#4
$2.3M15150%N/AN/A
#5
$1.4M90%N/AN/A
#6
$11.5M74-12%N/AN/A
#7
$0.4M27510%$236.7MN/A
#8
$4M51-74%$160MN/A
#9
$2.5M1633%N/AN/A
#10
$3.3M21-12%N/AN/A
Add Company

Oncocyte is a molecular diagnostics company whose mission is to provide actionable answers to physicians and patients at critical decision points along the lung cancer care continuum, to optimize diagnosis and treatment, improve patient outcomes, and reduce overall cost of care. For more information, visit www.oncocyte.com.

keywords:N/A

N/A

Total Funding

68

Number of Employees

$10.5M

Revenue (est)

-50%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oncocyte Corporation News

2022-04-13 - Oncocyte Corporation Announces Pricing of Registered Direct ...

IRVINE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), (“Oncocyte” or the “Company”),...

2022-04-13 - Broadwood Capital Engages in Discussions with OncoCyte Corporation

ONCOCYTE CORPORATION. OCX. Delayed Quote. Delayed - 04/14 04:00:00...

2022-03-30 - Oncocyte to Present New Data Confirming Association of IO ...

IRVINE, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to...

2015-05-15 - Stem cell genes are helping inform this startup’s approach to cancer diagnostics

OncoCyte actually draws its diagnostic capability from the kind of stem cell research going on at BioTime – because the company itself pivoted away from embryonic stem cell-based cancer therapeutics and into the diagnostics space. Several genes associated with embryonic stem cell growth are rea ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.9M680%N/A
#2
$16.5M683%N/A
#3
$9.2M68-7%N/A
#4
N/A688%N/A
#5
$20.1M6810%N/A